HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dai Maruyama Selected Research

forodesine

1/2019Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma.
12/2018Correction to: Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma.
1/2018Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review.
7/2012Phase I study of BCX1777 (forodesine) in patients with relapsed or refractory peripheral T/natural killer-cell malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dai Maruyama Research Topics

Disease

20Lymphoma (Lymphomas)
01/2022 - 08/2007
16Multiple Myeloma
09/2022 - 01/2008
14Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2022 - 11/2008
14Neoplasms (Cancer)
01/2022 - 07/2012
11B-Cell Lymphoma (Lymphoma, B Cell)
05/2022 - 11/2008
11Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 05/2007
10Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 01/2009
9Hodgkin Disease (Hodgkin's Disease)
10/2020 - 07/2014
8Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2019 - 01/2013
6Disease Progression
12/2020 - 07/2012
5Pneumonia (Pneumonitis)
12/2021 - 10/2010
5Thrombocytopenia (Thrombopenia)
01/2019 - 11/2010
5Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2019 - 01/2009
4Lymphopenia (Lymphocytopenia)
06/2021 - 03/2015
4Fever (Fevers)
06/2021 - 11/2008
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2021 - 01/2009
4Hematologic Neoplasms (Hematological Malignancy)
12/2020 - 08/2007
3Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
04/2022 - 03/2016
3Hepatitis
05/2021 - 09/2015
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
12/2019 - 07/2012
3Plasmacytoma
10/2019 - 01/2015
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2017 - 08/2007
3Infections
08/2016 - 07/2008
2Hypoalbuminemia
06/2021 - 03/2018
2Neutropenia
01/2019 - 12/2010
2Fatigue
03/2018 - 03/2016
2Opportunistic Infections (Opportunistic Infection)
01/2018 - 11/2008
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
11/2017 - 07/2012
2Abdominal Pain (Pain, Abdominal)
08/2016 - 05/2007
2Anemia
12/2010 - 11/2010
2Stomatitis
12/2010 - 11/2010
2Leukemia
09/2010 - 08/2007
1Extranodal NK-T-Cell Lymphoma
10/2022
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2022

Drug/Important Bio-Agent (IBA)

23Rituximab (Mabthera)FDA Link
01/2022 - 11/2008
10Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 11/2008
10Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 11/2008
9Prednisolone (Predate)FDA LinkGeneric
01/2021 - 11/2008
8Bortezomib (Velcade)FDA Link
12/2021 - 01/2008
8Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 11/2008
6AntibodiesIBA
09/2022 - 09/2015
6Brentuximab VedotinIBA
01/2020 - 07/2014
5Monoclonal AntibodiesIBA
12/2021 - 08/2011
5Dexamethasone (Maxidex)FDA LinkGeneric
06/2021 - 03/2015
4Antiviral Agents (Antivirals)IBA
05/2021 - 09/2015
4Epstein-Barr virus encoded RNA 1IBA
07/2019 - 01/2013
4forodesineIBA
01/2019 - 07/2012
3Transaminases (Aminotransferases)IBA
06/2021 - 11/2010
3Hepatitis B Surface Antigens (HBsAg)FDA Link
05/2021 - 09/2015
3DNA (Deoxyribonucleic Acid)IBA
05/2021 - 09/2015
3Lenalidomide (CC 5013)FDA Link
11/2020 - 01/2015
3ibrutinibIBA
01/2019 - 12/2016
3Adrenal Cortex Hormones (Corticosteroids)IBA
04/2017 - 03/2015
2Proteasome InhibitorsIBA
09/2022 - 01/2008
2Azacitidine (5 Azacytidine)FDA Link
01/2022 - 04/2017
2venetoclaxIBA
01/2022 - 03/2021
2Bendamustine HydrochlorideFDA Link
12/2021 - 04/2017
2pembrolizumabIBA
06/2021 - 11/2020
2Alanine Transaminase (SGPT)IBA
05/2021 - 03/2018
2Melphalan (Alkeran)FDA LinkGeneric
01/2021 - 01/2016
2Prednisone (Sone)FDA LinkGeneric
01/2021 - 01/2019
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
12/2020 - 09/2019
2LigandsIBA
10/2020 - 05/2018
2NivolumabIBA
10/2020 - 05/2017
2Immune Checkpoint InhibitorsIBA
01/2020 - 01/2016
2Anaplastic Lymphoma KinaseIBA
12/2019 - 07/2012
2carfilzomibIBA
10/2019 - 10/2018
2Immunoglobulin M (IgM)IBA
07/2019 - 01/2015
2Etoposide (VP 16)FDA LinkGeneric
01/2019 - 12/2010
2Purine-Nucleoside PhosphorylaseIBA
01/2019 - 01/2018
2Cytarabine (Cytosar-U)FDA LinkGeneric
09/2018 - 12/2010
2Thalidomide (Thalomid)FDA Link
05/2018 - 01/2015
2SteroidsIBA
08/2016 - 09/2015
2Vasopressins (Vasopressin)IBA
08/2016 - 05/2007
2Methotrexate (Mexate)FDA LinkGeneric
10/2015 - 12/2010
1AnthracyclinesIBA
10/2022
1B7-H1 AntigenIBA
04/2022
1Immune Checkpoint ProteinsIBA
04/2022
1Trinitrotoluene (TNT)IBA
01/2022
1obinutuzumabIBA
12/2021
1HLA-DRB1 Chains (HLA DRB1)IBA
12/2021
1Biomarkers (Surrogate Marker)IBA
12/2021
1pomalidomideIBA
06/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2021
1Surface Antigens (Surface Antigen)IBA
05/2021
1lipoarabinomannan (LAM)IBA
05/2021
1tazemetostatIBA
03/2021
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2021
1polatuzumab vedotinIBA
01/2021
1mogamulizumabIBA
12/2020

Therapy/Procedure

28Therapeutics
10/2022 - 11/2008
16Drug Therapy (Chemotherapy)
04/2022 - 07/2008
7Stem Cell Transplantation
05/2022 - 08/2016
3Hematopoietic Stem Cell Transplantation
04/2022 - 09/2010
2Induction Chemotherapy
05/2021 - 10/2020
2Autologous Transplantation
10/2020 - 01/2018
2Immunotherapy
01/2020 - 01/2016
2Cell Transplantation
01/2018 - 08/2007
2Transplantation
01/2018 - 01/2016
1Radiotherapy
02/2021